{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T02:04:29Z","timestamp":1779674669645,"version":"3.53.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"China Association for Promotion of Health Science and Technology","award":["JKHY2023003"],"award-info":[{"award-number":["JKHY2023003"]}]},{"name":"Capital Health Development Scientific Research Special Project of Beijing Municipal Health Commission","award":["2024-1-1023"],"award-info":[{"award-number":["2024-1-1023"]}]},{"name":"Clinical Key Project of Peking University Third Hospital","award":["BYSYRCYJ2023001"],"award-info":[{"award-number":["BYSYRCYJ2023001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04949-7","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T11:16:01Z","timestamp":1775560561000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive pan-cancer analysis of FSCN1 as a marker for prognosis and immunity"],"prefix":"10.1007","volume":"17","author":[{"given":"Rui","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanxin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changqing","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangliang","family":"Qiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"issue":"5","key":"4949_CR1","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1006\/jmbi.2000.4087","volume":"302","author":"CP Ponting","year":"2000","unstructured":"Ponting CP, Russell RB. Identification of distant homologues of fibroblast growth factors suggests a common ancestor for all beta-trefoil proteins. J Mol Biol. 2000;302(5):1041\u20137. https:\/\/doi.org\/10.1006\/jmbi.2000.4087.","journal-title":"J Mol Biol"},{"issue":"9","key":"4949_CR2","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/j.biocel.2005.05.004","volume":"37","author":"Y Hashimoto","year":"2005","unstructured":"Hashimoto Y, Skacel M, Adams JC. Roles of Fascin in human carcinoma motility and signaling: prospects for a novel biomarker? Int J Biochem Cell Biol. 2005;37(9):1787\u2013804. https:\/\/doi.org\/10.1016\/j.biocel.2005.05.004.","journal-title":"Int J Biochem Cell Biol"},{"issue":"8","key":"4949_CR3","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.7150\/jca.67977","volume":"13","author":"Z Li","year":"2022","unstructured":"Li Z, Shi J, Zhang N, Zheng X, Jin Y, Wen S, et al. FSCN1 acts as a promising therapeutic target in the blockade of tumor cell motility: a review of its function, mechanism, and clinical significance. J Cancer. 2022;13(8):2528\u201339. https:\/\/doi.org\/10.7150\/jca.67977.","journal-title":"J Cancer"},{"issue":"6","key":"4949_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.anndiagpath.2005.07.005","volume":"9","author":"AA Roma","year":"2005","unstructured":"Roma AA, Prayson RA. Fascin expression in 90 patients with glioblastoma multiforme. Ann Diagn Pathol. 2005;9(6):307\u201311. https:\/\/doi.org\/10.1016\/j.anndiagpath.2005.07.005.","journal-title":"Ann Diagn Pathol"},{"issue":"2","key":"4949_CR5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1593\/neo.07909","volume":"10","author":"JH Hwang","year":"2008","unstructured":"Hwang JH, Smith CA, Salhia B, Rutka JT. The role of Fascin in the migration and invasiveness of malignant glioma cells. Neoplasia. 2008;10(2):149\u201359. https:\/\/doi.org\/10.1593\/neo.07909.","journal-title":"Neoplasia"},{"issue":"1","key":"4949_CR6","doi-asserted-by":"publisher","first-page":"338","DOI":"10.4049\/jimmunol.166.1.338","volume":"166","author":"MM Al-Alwan","year":"2001","unstructured":"Al-Alwan MM, Rowden G, Lee TD, West KA. Fascin is involved in the antigen presentation activity of mature dendritic cells. J Immunol. 2001;166(1):338\u201345. https:\/\/doi.org\/10.4049\/jimmunol.166.1.338.","journal-title":"J Immunol"},{"issue":"11","key":"4949_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050710","volume":"7","author":"W Gao","year":"2012","unstructured":"Gao W, Zhang C, Feng Y, Chen G, Wen S, Huangfu H, et al. Fascin-1, Ezrin and Paxillin contribute to the malignant progression and are predictors of clinical prognosis in laryngeal squamous cell carcinoma. PLoS ONE. 2012;7(11):e50710. https:\/\/doi.org\/10.1371\/journal.pone.0050710.","journal-title":"PLoS ONE"},{"issue":"5","key":"4949_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1574-5","volume":"10","author":"Y Chen","year":"2019","unstructured":"Chen Y, Tian T, Li Z-Y, Wang C-Y, Deng R, Deng W-Y, et al. FSCN1 is an effective marker of poor prognosis and a potential therapeutic target in human tongue squamous cell carcinoma. Cell Death Dis. 2019;10(5):356. https:\/\/doi.org\/10.1038\/s41419-019-1574-5.","journal-title":"Cell Death Dis"},{"issue":"4","key":"4949_CR9","doi-asserted-by":"publisher","first-page":"856","DOI":"10.4103\/jcrt.JCRT_732_17","volume":"14","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Liang B, Dong H. Expression of Fascin_1 protein in cancer tissues of patients with nonsmall cell lung cancer and its relevance to patients\u2019 clinicopathologic features and prognosis. J Cancer Res Ther. 2018;14(4):856\u20139. https:\/\/doi.org\/10.4103\/jcrt.JCRT_732_17.","journal-title":"J Cancer Res Ther"},{"issue":"7","key":"4949_CR10","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1158\/1078-0432.CCR-04-1378","volume":"11","author":"Y Hashimoto","year":"2005","unstructured":"Hashimoto Y, Ito T, Inoue H, Okumura T, Tanaka E, Tsunoda S, et al. Prognostic significance of Fascin overexpression in human esophageal squamous cell carcinoma. Clin Cancer Res. 2005;11(7):2597\u2013605. https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-1378.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"4949_CR11","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1136\/jcp.2005.032730","volume":"59","author":"H Zhang","year":"2006","unstructured":"Zhang H, Xu L, Xiao D, Xie J, Zeng H, Cai W, et al. Fascin is a potential biomarker for early-stage oesophageal squamous cell carcinoma. J Clin Pathol. 2006;59(9):958\u201364. https:\/\/doi.org\/10.1136\/jcp.2005.032730.","journal-title":"J Clin Pathol"},{"issue":"3\u20134","key":"4949_CR12","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1159\/000081327","volume":"67","author":"Y Hashimoto","year":"2004","unstructured":"Hashimoto Y, Shimada Y, Kawamura J, Yamasaki S, Imamura M. The prognostic relevance of Fascin expression in human gastric carcinoma. Oncology. 2004;67(3\u20134):262\u201370. https:\/\/doi.org\/10.1159\/000081327.","journal-title":"Oncology"},{"issue":"9","key":"4949_CR13","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1369\/jhc.7A7235.2007","volume":"55","author":"W-C Tsai","year":"2007","unstructured":"Tsai W-C, Jin J-S, Chang W-K, Chan D-C, Yeh M-K, Cherng S-C, et al. Association of Cortactin and Fascin-1 expression in gastric adenocarcinoma: Correlation with clinicopathological parameters. J Histochem Cytochem. 2007;55(9):955\u201362. https:\/\/doi.org\/10.1369\/jhc.7A7235.2007.","journal-title":"J Histochem Cytochem"},{"issue":"2","key":"4949_CR14","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.humpath.2008.06.029","volume":"40","author":"T Iguchi","year":"2009","unstructured":"Iguchi T, Aishima S, Taketomi A, Nishihara Y, Fujita N, Sanefuji K, et al. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis. Hum Pathol. 2009;40(2):174\u201380. https:\/\/doi.org\/10.1016\/j.humpath.2008.06.029.","journal-title":"Hum Pathol"},{"issue":"2","key":"4949_CR15","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1159\/000346559","volume":"91","author":"J Bi","year":"2013","unstructured":"Bi J, Zhu Y, Chen X, Yu M, Zhang Y, Li B, et al. The role of Fascin in migration and invasion of urothelial carcinoma of the bladder. Urol Int. 2013;91(2):227\u201335. https:\/\/doi.org\/10.1159\/000346559.","journal-title":"Urol Int"},{"key":"4949_CR16","doi-asserted-by":"publisher","unstructured":"Jin J-S, Yu C-P, Sun G-H, Lin Y-F, Chiang H, Chao T-K, Tsai W-C, Sheu L-F. Increasing expression of Fascin in renal cell carcinoma associated with clinicopathological parameters of aggressiveness. Histol Histopathol. 2006;21(12):1287\u201393. https:\/\/doi.org\/10.14670\/HH-21.1287.","DOI":"10.14670\/HH-21.1287"},{"issue":"7","key":"4949_CR17","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.humpath.2005.05.005","volume":"36","author":"G-X Tong","year":"2005","unstructured":"Tong G-X, Yee H, Chiriboga L, Hernandez O, Waisman J. Fascin-1 expression in papillary and invasive urothelial carcinomas of the urinary bladder. Hum Pathol. 2005;36(7):741\u20136. https:\/\/doi.org\/10.1016\/j.humpath.2005.05.005.","journal-title":"Hum Pathol"},{"issue":"9","key":"4949_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13092013","volume":"13","author":"EF Franco","year":"2021","unstructured":"Franco EF, Rana P, Cruz A, Calder\u00f3n VV, Azevedo V, Ramos RTJ, et al. Performance comparison of deep learning autoencoders for cancer subtype detection using multi-omics data. Cancers (Basel). 2021;13(9):2013. https:\/\/doi.org\/10.3390\/cancers13092013.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"4949_CR19","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nbt.3772","volume":"35","author":"J Vivian","year":"2017","unstructured":"Vivian J, Rao AA, Nothaft FA, Ketchum C, Armstrong J, Novak A, et al. Toil enables reproducible, open source, big biomedical data analyses. Nat Biotechnol. 2017;35(4):314\u20136. https:\/\/doi.org\/10.1038\/nbt.3772.","journal-title":"Nat Biotechnol"},{"key":"4949_CR20","doi-asserted-by":"publisher","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson \u00c5, Kampf C, Sj\u00f6stedt E, Asplund A, Olsson I, Edlund K, Lundberg E, Navani S, Szigyarto CA-K, Odeberg J, Djureinovic D, Takanen JO, Hober S, Alm T, Edqvist P-H, Berling H, Tegel H, Mulder J, Rockberg J, Nilsson P, Schwenk JM, Hamsten M, von Feilitzen K, Forsberg M, Persson L, Johansson F, Zwahlen M, von Heijne G, Nielsen J, Pont\u00e9n F. Proteomics. Tissue-based map of the human proteome. Science. 2015;347(6220):1260419. https:\/\/doi.org\/10.1126\/science.1260419.","DOI":"10.1126\/science.1260419"},{"key":"4949_CR21","unstructured":"Detection of immune checkpoint receptors\u2014a current challenge in clinical flow cytometry. https:\/\/pubmed.ncbi.nlm.nih.gov\/34276685\/ (accessed 2025-12-11)."},{"issue":"5","key":"4949_CR22","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401\u20134. https:\/\/doi.org\/10.1158\/2159-8290.CD-12-0095.","journal-title":"Cancer Discov"},{"issue":"9","key":"4949_CR23","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a019505","volume":"8","author":"SB Baylin","year":"2016","unstructured":"Baylin SB, Jones PA. Epigenetic determinants of cancer. Cold Spring Harb Perspect Biol. 2016;8(9):a019505. https:\/\/doi.org\/10.1101\/cshperspect.a019505.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"4949_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13072-019-0316-3","volume":"12","author":"Y Li","year":"2019","unstructured":"Li Y, Ge D, Lu C. The SMART app: an interactive web application for comprehensive DNA methylation analysis and visualization. Epigenetics Chromatin. 2019;12(1):71. https:\/\/doi.org\/10.1186\/s13072-019-0316-3.","journal-title":"Epigenetics Chromatin"},{"issue":"D1","key":"4949_CR25","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING V11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607\u201313. https:\/\/doi.org\/10.1093\/nar\/gky1131.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"4949_CR26","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang L-G, Han Y, He Q-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137. https:\/\/doi.org\/10.1089\/omi.2011.0118.","journal-title":"OMICS"},{"issue":"5","key":"4949_CR27","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/s41596-020-0312-x","volume":"15","author":"Y Yan","year":"2020","unstructured":"Yan Y, Tao H, He J, Huang S-Y. The HDOCK server for integrated protein-protein docking. Nat Protoc. 2020;15(5):1829\u201352. https:\/\/doi.org\/10.1038\/s41596-020-0312-x.","journal-title":"Nat Protoc"},{"issue":"W1","key":"4949_CR28","doi-asserted-by":"publisher","first-page":"W365","DOI":"10.1093\/nar\/gkx407","volume":"45","author":"Y Yan","year":"2017","unstructured":"Yan Y, Zhang D, Zhou P, Li B, Huang S-Y. HDOCK: a web server for protein-protein and protein-DNA\/RNA docking based on a hybrid strategy. Nucleic Acids Res. 2017;45(W1):W365\u201373. https:\/\/doi.org\/10.1093\/nar\/gkx407.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"4949_CR29","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/prot.25234","volume":"85","author":"Y Yan","year":"2017","unstructured":"Yan Y, Wen Z, Wang X, Huang S-Y. Addressing recent docking challenges: a hybrid strategy to integrate template-based and free protein-protein docking. Proteins. 2017;85(3):497\u2013512. https:\/\/doi.org\/10.1002\/prot.25234.","journal-title":"Proteins"},{"key":"4949_CR30","doi-asserted-by":"publisher","unstructured":"UniProt Consortium, T. UniProt: The universal protein knowledgebase. Nucleic Acids Res. 2018;46(5):2699. https:\/\/doi.org\/10.1093\/nar\/gky092.","DOI":"10.1093\/nar\/gky092"},{"issue":"5","key":"4949_CR31","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10822-010-9352-6","volume":"24","author":"D Seeliger","year":"2010","unstructured":"Seeliger D, de Groot BL. Ligand docking and binding site analysis with PyMOL and Autodock\/Vina. J Comput Aided Mol Des. 2010;24(5):417\u201322. https:\/\/doi.org\/10.1007\/s10822-010-9352-6.","journal-title":"J Comput Aided Mol Des"},{"issue":"10","key":"4949_CR32","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","volume":"51","author":"RA Laskowski","year":"2011","unstructured":"Laskowski RA, Swindells MB. LigPlot+: Multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model. 2011;51(10):2778\u201386. https:\/\/doi.org\/10.1021\/ci200227u.","journal-title":"J Chem Inf Model"},{"issue":"7","key":"4949_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku077","volume":"42","author":"S-Y Huang","year":"2014","unstructured":"Huang S-Y, Zou X. A knowledge-based scoring function for protein-RNA interactions derived from a statistical mechanics-based iterative method. Nucleic Acids Res. 2014;42(7):e55. https:\/\/doi.org\/10.1093\/nar\/gku077.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"4949_CR34","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/prot.21949","volume":"72","author":"S-Y Huang","year":"2008","unstructured":"Huang S-Y, Zou X. An iterative knowledge-based scoring function for protein-protein recognition. Proteins. 2008;72(2):557\u201379. https:\/\/doi.org\/10.1002\/prot.21949.","journal-title":"Proteins"},{"issue":"D1","key":"4949_CR35","doi-asserted-by":"publisher","first-page":"D900","DOI":"10.1093\/nar\/gky939","volume":"47","author":"H Yuan","year":"2019","unstructured":"Yuan H, Yan M, Zhang G, Liu W, Deng C, Liao G, et al. CancerSEA: a cancer single-cell state atlas. Nucleic Acids Res. 2019;47(D1):D900\u20138. https:\/\/doi.org\/10.1093\/nar\/gky939.","journal-title":"Nucleic Acids Res"},{"issue":"21","key":"4949_CR36","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1093\/bioinformatics\/bty411","volume":"34","author":"C-J Liu","year":"2018","unstructured":"Liu C-J, Hu F-F, Xia M-X, Han L, Zhang Q, Guo A-Y. GSCALite: a web server for gene set cancer analysis. Bioinformatics. 2018;34(21):3771\u20132. https:\/\/doi.org\/10.1093\/bioinformatics\/bty411.","journal-title":"Bioinformatics"},{"key":"4949_CR37","doi-asserted-by":"publisher","unstructured":"Maeser D, Gruener RF, Huang RS. oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform. 2021;22(6):bbab260. https:\/\/doi.org\/10.1093\/bib\/bbab260.","DOI":"10.1093\/bib\/bbab260"},{"issue":"6","key":"4949_CR38","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nrc822","volume":"2","author":"JP Thiery","year":"2002","unstructured":"Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002;2(6):442\u201354. https:\/\/doi.org\/10.1038\/nrc822.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"4949_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2025.101771","volume":"13","author":"C Liu","year":"2026","unstructured":"Liu C, Wang S, Zhang X, Han Y, Tan M, Fan J, et al. The biomechanical signature of tumor invasion. Genes Dis. 2026;13(1):101771. https:\/\/doi.org\/10.1016\/j.gendis.2025.101771.","journal-title":"Genes Dis"},{"issue":"24","key":"4949_CR40","doi-asserted-by":"publisher","first-page":"10433","DOI":"10.1158\/0008-5472.CAN-10-2638","volume":"70","author":"S-H Chiou","year":"2010","unstructured":"Chiou S-H, Wang M-L, Chou Y-T, Chen C-J, Hong C-F, Hsieh W-J, et al. Coexpression of Oct4 and nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res. 2010;70(24):10433\u201344. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-2638.","journal-title":"Cancer Res"},{"key":"4949_CR41","doi-asserted-by":"publisher","unstructured":"Li J, Lu J, Ye Z, Han X, Zheng X, Hou H, Chen W, Li X, Zhao L. 20(S)-Rg3 blocked epithelial-mesenchymal transition through DNMT3A\/miR-145\/FSCN1 in Ovarian cancer. Oncotarget. 2017;8(32):53375\u201386. https:\/\/doi.org\/10.18632\/oncotarget.18482.","DOI":"10.18632\/oncotarget.18482"},{"key":"4949_CR42","unstructured":"FSCN1 is upregulated by SNAI2 and promotes epithelial to mesenchymal transition in head and neck squamous cell carcinoma. https:\/\/pubmed.ncbi.nlm.nih.gov\/28488774\/ (accessed 2025-12-11)."},{"key":"4949_CR43","doi-asserted-by":"publisher","unstructured":"Pan Y, Chen J, Tao L, Zhang K, Wang R, Chu X, Chen L. Long noncoding RNA ROR regulates chemoresistance in docetaxel-resistant lung adenocarcinoma cells via epithelial mesenchymal transition pathway. Oncotarget. 2017;8(20):33144\u201358. https:\/\/doi.org\/10.18632\/oncotarget.16562.","DOI":"10.18632\/oncotarget.16562"},{"issue":"9","key":"4949_CR44","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.prp.2018.06.018","volume":"214","author":"G Wang","year":"2018","unstructured":"Wang G, Gu Y, Lu W, Liu X, Fu H. Fascin1 promotes gastric cancer progression by facilitatingcell migrationand epithelial-mesenchymal transition. Pathol Res Pract. 2018;214(9):1362\u20139. https:\/\/doi.org\/10.1016\/j.prp.2018.06.018.","journal-title":"Pathol Res Pract"},{"issue":"1","key":"4949_CR45","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1021\/pr8006478","volume":"8","author":"VG Keshamouni","year":"2009","unstructured":"Keshamouni VG, Jagtap P, Michailidis G, Strahler JR, Kuick R, Reka AK, et al. Temporal quantitative proteomics by iTRAQ 2D-LC-MS\/MS and corresponding mRNA expression analysis identify post-transcriptional modulation of actin-cytoskeleton regulators during TGF-beta-induced epithelial-mesenchymal transition. J Proteome Res. 2009;8(1):35\u201347. https:\/\/doi.org\/10.1021\/pr8006478.","journal-title":"J Proteome Res"},{"issue":"1","key":"4949_CR46","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41420-025-02503-y","volume":"11","author":"D-M Xu","year":"2025","unstructured":"Xu D-M, Chen L-X, Xue T, Zhuang X-Y, Wei L-C, Han H, et al. Decoding the impact of MMP1+ malignant subsets on tumor-immune interactions: insights from single-cell and spatial transcriptomics. Cell Death Discov. 2025;11(1):244. https:\/\/doi.org\/10.1038\/s41420-025-02503-y.","journal-title":"Cell Death Discov"},{"issue":"5","key":"4949_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2025.101529","volume":"12","author":"S Tian","year":"2025","unstructured":"Tian S, Chen X, Li J. Zinc finger transcription factor ZNF24 inhibits colorectal cancer growth and metastasis by suppressing MMP2 transcription. Genes Dis. 2025;12(5):101529. https:\/\/doi.org\/10.1016\/j.gendis.2025.101529.","journal-title":"Genes Dis"},{"issue":"7","key":"4949_CR48","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3390\/cimb47070557","volume":"47","author":"A Veljkovic","year":"2025","unstructured":"Veljkovic A, Stanojevic G, Brankovic B, Roumeliotis S, Leivaditis K, Djordjevic B, et al. MMP-9 activation via ROS\/NF-\u03baB signaling in colorectal cancer progression: molecular insights and prognostic-therapeutic perspectives. Curr Issues Mol Biol. 2025;47(7):557. https:\/\/doi.org\/10.3390\/cimb47070557.","journal-title":"Curr Issues Mol Biol"},{"issue":"1","key":"4949_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01694-6","volume":"9","author":"M Tu","year":"2023","unstructured":"Tu M, Yin X, Zhuang W, Lin X, Xia Y, Huang Z, et al. NSG1 promotes glycolytic metabolism to enhance esophageal squamous cell carcinoma EMT process by upregulating TGF-\u03b2. Cell Death Discov. 2023;9(1):391. https:\/\/doi.org\/10.1038\/s41420-023-01694-6.","journal-title":"Cell Death Discov"},{"key":"4949_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107753","volume":"221","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Yu D. Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther. 2021;221:107753. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107753.","journal-title":"Pharmacol Ther"},{"issue":"3","key":"4949_CR51","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1002\/med.21765","volume":"41","author":"H Sadeghi Rad","year":"2021","unstructured":"Sadeghi Rad H, Monkman J, Warkiani ME, Ladwa R, O\u2019Byrne K, Rezaei N, et al. Understanding the tumor microenvironment for effective immunotherapy. Med Res Rev. 2021;41(3):1474\u201398. https:\/\/doi.org\/10.1002\/med.21765.","journal-title":"Med Res Rev"},{"issue":"3","key":"4949_CR52","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1549-8719.2010.00029.x","volume":"17","author":"D Fukumura","year":"2010","unstructured":"Fukumura D, Duda DG, Munn LL, Jain RK. Tumor microvasculature and microenvironment: novel insights through intravital imaging in pre-clinical models. Microcirculation. 2010;17(3):206\u201325. https:\/\/doi.org\/10.1111\/j.1549-8719.2010.00029.x.","journal-title":"Microcirculation"},{"issue":"17","key":"4949_CR53","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1200\/JCO.2014.59.4358","volume":"33","author":"MA Postow","year":"2015","unstructured":"Postow MA, Callahan MK, Wolchok JD. Immune checkpoint blockade in cancer therapy. J Clin Oncol. 2015;33(17):1974\u201382. https:\/\/doi.org\/10.1200\/JCO.2014.59.4358.","journal-title":"J Clin Oncol"},{"issue":"4","key":"4949_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19041166","volume":"19","author":"GP Pfeifer","year":"2018","unstructured":"Pfeifer GP. Defining driver DNA methylation changes in human cancer. Int J Mol Sci. 2018;19(4):1166. https:\/\/doi.org\/10.3390\/ijms19041166.","journal-title":"Int J Mol Sci"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04949-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04949-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04949-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T01:59:49Z","timestamp":1779674389000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04949-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4949"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04949-7","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"31 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"763"}}